The average one-year price target for Moleculin Biotech (NASDAQCM:MBRX) (LSE:0K2H) has been revised to $244.80 / share. This is an increase of 1,900.00% from the prior estimate of $12.24 dated September 29, 2026. These figures represent aggregate analyst targets compiled by Finte